By Dr Briony Kate Larance

Journal articles

Campbell G; Settumba S; Hopkins R; Nielsen S; Larance B; Bruno R; Cohen M; Degenhardt L; Shanahan M, 2025, 'A discrete choice experiment: Understanding patient preferences for managing chronic non-cancer pain', European Journal of Pain, 29, http://dx.doi.org/10.1002/ejp.4760

Pocuca N; Campbell G; Barnett A; Beck AK; Ellem R; Quinn CA; Kelly PJ; Larance B; Baker AL; Connor JP; Marsden J; Chan GCK; Connelly L; Lenzen S; Farrell M; Stirling R; Hudson S; Hides L, 2025, 'A mixed-methods study of staff perspectives on the barriers and facilitators to the implementation of patient-reported routine outcome measures and feedback in alcohol and other drug treatment', Drug and Alcohol Review, 44, pp. 759 - 771, http://dx.doi.org/10.1111/dar.14007

Beck AK; Larance B; Manning V; Deane FP; Baker AL; Hides L; Shakeshaft A; Argent A; Kelly PJ, 2025, 'Exploring the potential of Self-Management and Recovery Training (SMART Recovery) mutual-help groups for supporting people who use methamphetamine: A qualitative study examining participant experience of initiation and engagement', Journal of Substance Use and Addiction Treatment, 169, http://dx.doi.org/10.1016/j.josat.2024.209570

Hatton EL; Kelly PJ; Bruno R; Neale J; Larance B, 2025, 'Measuring recovery among people who have completed residential rehabilitation: Factor structure and scoring of the substance use recovery evaluator', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.14004

Larance B; Ingram I; Haynes C; Buckfield L; Goh CWM; Kelly PJ, 2025, 'New South Wales alcohol and other drug service providers' perceptions of the relative importance of client variables for determining treatment need', Drug and Alcohol Review, 44, pp. 195 - 225, http://dx.doi.org/10.1111/dar.13952

Settumba S; Shahbazi J; Byrne M; Degenhardt L; Grebely J; Larance B; Nielsen S; Lintzeris N; Ali R; Rodgers C; Blazey A; Weiss R; Dunlop A; McDonough M; Cook J; Farrell M, 2025, 'Provider costs of treating opioid dependence with extended-release buprenorphine in Australia', Drug and Alcohol Review, 44, pp. 179 - 194, http://dx.doi.org/10.1111/dar.13956

Pocuca N; Tisdale C; Campbell G; Beck AK; Ellem R; Quinn CA; Kelly PJ; Larance B; Baker AL; Connor JP; Marsden J; Chan GCK; Connelly L; Lenzen S; Farrell M; Hides L, 2025, 'Routine outcome monitoring and feedback in alcohol and other drug treatment: A qualitative study of client perspectives on implementation', Drug and Alcohol Review, 44, pp. 226 - 238, http://dx.doi.org/10.1111/dar.13962

Campbell G; Larance B, 2024, 'Commentary on Yang et al.: The need for a renewed focus on identifying and responding to chronic pain among people with substance use disorders', Addiction, 119, pp. 1902 - 1903, http://dx.doi.org/10.1111/add.16654

Wells M; Kelly PJ; Mullaney L; Lee ML; Stirling R; Etter S; Larance B, 2024, 'Predictors of alcohol and other drug treatment completion among young people accessing residential and community-based treatment: A retrospective analysis of routinely collected service data', Addiction, 119, pp. 1813 - 1825, http://dx.doi.org/10.1111/add.16602

Wells M; Kelly PJ; Robson D; Haynes C; Hatton E; Larance B, 2024, 'Systematic review of treatment completion rates and correlates among young people accessing alcohol and other drug treatment', Drug and Alcohol Dependence, 262, http://dx.doi.org/10.1016/j.drugalcdep.2024.111376

Haynes CJ; Beck AK; Wells M; Hatton EL; Kelly PJ; Tan WJ; Larance B, 2024, 'Women and opioid use disorder treatment: A scoping review of experiences, use of patient-reported experience measures, and integration of person-centred care principles', International Journal of Drug Policy, 130, http://dx.doi.org/10.1016/j.drugpo.2024.104520

Rushton CM; Kelly PJ; Thomas T; Beck AK; Townsend C; Baker AL; Manning V; Argent A; Deane FP; Hides L; Hitsman B; Velleman R; Velleman G; Larance B, 2024, 'SMART Family and Friends: Feasibility and outcomes of a video-conference delivered intervention for families impacted by another's methamphetamine use', Journal of Substance Use and Addiction Treatment, 161, http://dx.doi.org/10.1016/j.josat.2024.209355

Farrell M; Shahbazi J; Chambers M; Byrne M; Gholami J; Zahra E; Grebely J; Lintzeris N; Larance B; Ali R; Nielsen S; Dunlop A; Dore GJ; McDonough M; Montebello M; Weiss R; Rodgers C; Cook J; Degenhardt L, 2024, '96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104390

Tran AD; Grebely J; Chambers M; Degenhardt L; Farrell M; Bajis S; Larance B, 2024, 'Health utility among people who regularly use opioids in Australia', Drug and Alcohol Review, 43, pp. 997 - 1012, http://dx.doi.org/10.1111/dar.13823

van de Ven K; Deane FP; Kelly PJ; Larance B; Beck AK, 2024, 'Online SMART Recovery mutual-help groups: a comparison of the characteristics and experiences of men living in rural and urban regions of Australia', Rural and Remote Health, 24, http://dx.doi.org/10.22605/RRH8861

Beck AK; Waks S; Argent A; Deane FP; Larance B; Manning V; Baker AL; Hides L; Kelly PJ, 2023, 'The benefits and challenges of virtual SMART recovery mutual-help groups: Participant and facilitator perspectives', International Journal of Drug Policy, 120, http://dx.doi.org/10.1016/j.drugpo.2023.104174

Degenhardt L; Clark B; Macpherson G; Leppan O; Nielsen S; Zahra E; Larance B; Kimber J; Martino-Burke D; Hickman M; Farrell M, 2023, 'Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies', The Lancet Psychiatry, 10, pp. 386 - 402, http://dx.doi.org/10.1016/S2215-0366(23)00095-0

Rushton C; Kelly PJ; Raftery D; Beck A; Larance B, 2023, 'The effectiveness of psychosocial interventions for family members impacted by another's substance use: A systematic review and meta-analysis', Drug and Alcohol Review, 42, pp. 960 - 977, http://dx.doi.org/10.1111/dar.13607

Beck AK; Larance B; Baker AL; Deane FP; Manning V; Hides L; Kelly PJ, 2023, 'Supporting people affected by problematic alcohol, substance use and other behaviours under pandemic conditions: A pragmatic evaluation of how SMART recovery Australia responded to COVID-19', Addictive Behaviors, 139, http://dx.doi.org/10.1016/j.addbeh.2022.107577

Robinson LD; Walter EE; Deane FP; Larance BK, 2023, 'Comorbid eating disorders among women receiving treatment for substance use disorders: a systematic review and meta-analysis', Addiction Research and Theory, 31, pp. 114 - 126, http://dx.doi.org/10.1080/16066359.2022.2127692

Beck AK; Larance B; Manning V; Hides L; Baker AL; Deane FP; Shakeshaft A; Raftery D; Kelly PJ, 2023, 'Online SMART Recovery mutual support groups: Characteristics and experience of adults seeking treatment for methamphetamine compared to those seeking treatment for other addictive behaviours', Drug and Alcohol Review, 42, pp. 20 - 26, http://dx.doi.org/10.1111/dar.13544

Nielsen S; Tse WC; Larance B, 2022, 'Opioid agonist treatment for people who are dependent on pharmaceutical opioids', Cochrane Database of Systematic Reviews, 2022, http://dx.doi.org/10.1002/14651858.CD011117.pub3

Osborne B; Larance B; Ivers R; Deane FP; Robinson LD; Kelly PJ, 2022, 'Systematic review of guidelines for managing physical health during treatment for substance use disorders: Implications for the alcohol and other drug workforce', Drug and Alcohol Review, 41, pp. 1367 - 1390, http://dx.doi.org/10.1111/dar.13504

Robinson LD; Kelly PJ; Larance BK; Griffiths S; Deane FP, 2022, 'Eating Disorder Behaviours and Substance Use in Women Attending Treatment for Substance Use Disorders: a Latent Class Analysis', International Journal of Mental Health and Addiction, 20, pp. 2006 - 2023, http://dx.doi.org/10.1007/s11469-021-00497-z

Hopkins RE; Campbell G; Degenhardt L; Lintzeris N; Larance B; Nielsen S; Gisev N, 2022, 'Self-reported challenges obtaining ongoing prescription opioids among Australians with chronic non-cancer pain', International Journal of Drug Policy, 105, http://dx.doi.org/10.1016/j.drugpo.2022.103708

Zahra E; Chen R; Nielsen S; Tran AD; Santo T; Degenhardt L; Farrell M; Byrne J; Ali R; Larance B, 2022, 'Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross-sectional survey of Australian treatment clients', Drug and Alcohol Review, 41, pp. 841 - 850, http://dx.doi.org/10.1111/dar.13437

Farrell M; Shahbazi J; Byrne M; Grebely J; Lintzeris N; Chambers M; Larance B; Ali R; Nielsen S; Dunlop A; Dore GJ; McDonough M; Montebello M; Nicholas T; Weiss R; Rodgers C; Cook J; Degenhardt L, 2022, 'Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence', International Journal of Drug Policy, 100, http://dx.doi.org/10.1016/j.drugpo.2021.103492

Tran AD; Chen R; Nielsen S; Zahra E; Degenhardt L; Santo T; Farrell M; Larance B, 2022, 'Economic analysis of out-of-pocket costs among people in opioid agonist treatment: A cross-sectional survey in three Australian jurisdictions', International Journal of Drug Policy, 99, http://dx.doi.org/10.1016/j.drugpo.2021.103472

Kelly PJ; Hatton EL; Hinsley K; Davis E; Larance B, 2021, 'Preliminary psychometric evaluation of the patient reported experience measure for addiction treatment (PREMAT)', Addictive Behaviors, 123, http://dx.doi.org/10.1016/j.addbeh.2021.107048

Kelly PJ; McCreanor K; Beck AK; Ingram I; O'Brien D; King A; McGlaughlin R; Argent A; Ruth M; Hansen BS; Andersen D; Manning V; Shakeshaft A; Hides L; Larance B, 2021, 'SMART Recovery International and COVID-19: Expanding the reach of mutual support through online groups', Journal of Substance Abuse Treatment, 131, http://dx.doi.org/10.1016/j.jsat.2021.108568

Kelly PJ; Beck AK; Deane FP; Larance B; Baker AL; Hides L; Manning V; Shakeshaft A; Neale J; Kelly JF; Oldmeadow C; Searles A; Palazzi K; Lawson K; Treloar C; Gray RM; Argent A; McGlaughlin R, 2021, 'Feasibility of a mobile health app for routine outcome monitoring and feedback in SMART recovery mutual support groups: Stage 1 mixed methods pilot study', Journal of Medical Internet Research, 23, http://dx.doi.org/10.2196/25217

Nielsen S; Gisev N; Leung J; Clare P; Bruno R; Lintzeris N; Larance B; Blyth F; Hall W; Cohen M; Degenhardt L; Farrell M; Campbell G, 2021, 'Clinical correlates and outcomes associated with pregabalin use among people prescribed opioids for chronic non-cancer pain: A five-year prospective cohort study', British Journal of Clinical Pharmacology, 87, pp. 3092 - 3104, http://dx.doi.org/10.1111/bcp.14715

Beck AK; Larance B; Deane FP; Baker AL; Manning V; Hides L; Shakeshaft A; Argent A; Kelly PJ, 2021, 'The use of Australian SMART Recovery groups by people who use methamphetamine: Analysis of routinely-collected nationwide data', Drug and Alcohol Dependence, 225, http://dx.doi.org/10.1016/j.drugalcdep.2021.108814

Nielsen S; Sanfilippo P; Belackova V; Day C; Silins E; Lintzeris N; Bruno R; Grebely J; Lancaster K; Ali R; Bell J; Dietze P; Degenhardt L; Farrell M; Larance B, 2021, 'Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian cities', Addiction, 116, pp. 1482 - 1494, http://dx.doi.org/10.1111/add.15297

Osborne B; Kelly PJ; Robinson LD; Ivers R; Deane FP; Larance B, 2021, 'Facilitators and barriers to integrating physical health care during treatment for substance use: A socio-ecological analysis', Drug and Alcohol Review, 40, pp. 607 - 616, http://dx.doi.org/10.1111/dar.13197

Kelly PJ; Deane FP; Davis EL; Hudson S; Robinson LD; Keane CA; Hatton EL; Larance B, 2021, 'Routine outcome measurement in specialist non-government alcohol and other drug treatment services: Establishing effectiveness indicators for the NADAbase', Drug and Alcohol Review, 40, pp. 540 - 552, http://dx.doi.org/10.1111/dar.13191

Degenhardt L; Hungerford P; Nielsen S; Bruno R; Larance B; Clare PJ; Dobbins T; Hall W; Cohen M; Blyth F; Lintzeris N; Farrell M; Campbell G, 2021, 'Pharmaceutical Opioid Use Patterns and Indicators of Extramedical Use and Harm in Adults with Chronic Noncancer Pain, 2012-2018', JAMA Network Open, 4, http://dx.doi.org/10.1001/jamanetworkopen.2021.3059

Darke S; Duflou J; Larance B; Farrell M; Lappin J, 2021, 'Characteristics and circumstances of death related to buprenorphine toxicity in Australia', Drug and Alcohol Dependence, 218, http://dx.doi.org/10.1016/j.drugalcdep.2020.108360

Campbell G; Noghrehchi F; Nielsen S; Clare P; Bruno R; Lintzeris N; Cohen M; Blyth F; Hall W; Larance B; Hungerford P; Dobbins T; Farrell M; Degenhardt L, 2020, 'Risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: Findings from a 5-year prospective cohort study', EClinicalMedicine, 28, http://dx.doi.org/10.1016/j.eclinm.2020.100592

Larance B; Byrne M; Lintzeris N; Nielsen S; Grebely J; Degenhardt L; Shahbazi J; Shanahan M; Lancaster K; Dore G; Ali R; Farrell M; Treloar C, 2020, 'Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: Protocol for the CoLAB study', BMJ Open, 10, pp. e034389, http://dx.doi.org/10.1136/bmjopen-2019-034389

Kelly PJ; Beck AK; Baker AL; Deane FP; Hides L; Manning V; Shakeshaft A; Larance B; Neale J; Kelly J; Oldmeadow C; Searles A; Treloar C; Gray RM; Argent A; McGlaughlin R, 2020, 'Feasibility of a mobile health app for routine outcome monitoring and feedback in mutual support groups coordinated by SMART recovery Australia: Protocol for a pilot study', JMIR Research Protocols, 9, http://dx.doi.org/10.2196/15113

Larance B; Degenhardt L; Grebely J; Nielsen S; Bruno R; Dietze P; Lancaster K; Larney S; Santo T; Shanahan M; Memedovic S; Ali R; Farrell M, 2020, 'Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia', Addiction, 115, pp. 1295 - 1305, http://dx.doi.org/10.1111/add.14941

Osborne B; Kelly PJ; Larance B; Robinson LD; Ivers R; Deane FP; Webber A; Kelly D, 2020, 'Substance Use and Co-occurring Physical Health Problems: File Review of a Residential Drug and Alcohol Treatment Service', Journal of Dual Diagnosis, 16, pp. 250 - 259, http://dx.doi.org/10.1080/15504263.2019.1704960

Santo T; Larance B; Bruno R; Gisev N; Nielsen S; Degenhardt L; Campbell G, 2020, 'Correlates of indicators of potential extra-medical opioid use in people prescribed opioids for chronic non-cancer pain', Drug and Alcohol Review, 39, pp. 128 - 134, http://dx.doi.org/10.1111/dar.13021

Jacka B; Larance B; Copeland J; Burns L; Farrell M; Jackson E; Degenhardt L, 2020, 'Health care engagement behaviors of men who use performance- and image-enhancing drugs in Australia', Substance Abuse, 41, pp. 139 - 145, http://dx.doi.org/10.1080/08897077.2019.1635954

Nielsen S; Picco L; Campbell G; Lintzeris N; Larance B; Farrell M; Degenhardt L; Bruno R, 2020, 'Development of a brief patient-administered screening tool for prescription opioid dependence for primary care settings', Pain Medicine (United States), 21, pp. E79 - E88, http://dx.doi.org/10.1093/pm/pnz213

Peacock A; Gisev N; Memedovic S; Larance B; Brown J; Cairns R; Buckley N; Farrell M; Degenhardt L, 2020, 'Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study.', Drug Alcohol Depend, 206, pp. 107697, http://dx.doi.org/10.1016/j.drugalcdep.2019.107697

Gisev N; Nielsen S; Campbell G; Santo T; Mant A; Bruno R; Cohen M; Hall WD; Larance B; Lintzeris N; Farrell M; Degenhardt L, 2019, 'Antidepressant Use among People Prescribed Opioids for Chronic Noncancer Pain', Pain Medicine (United States), 20, pp. 2450 - 2458, http://dx.doi.org/10.1093/pm/pnz009

Darke S; Farrell M; Duflou J; Larance B; Lappin J, 2019, 'Circumstances of death of opioid users being treated with naltrexone', Addiction, 114, pp. 2000 - 2007, http://dx.doi.org/10.1111/add.14729

Campbell G; Larance B; Lintzeris N, 2019, 'Regulatory and other responses to the pharmaceutical opioid problem', Medical Journal of Australia, 211, pp. 237 - 237.e1, http://dx.doi.org/10.5694/mja2.50303

Back to profile page